Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
about
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open QuestionsVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerTrial Watch:: Oncolytic viruses for cancer therapyUnderstanding and altering cell tropism of vesicular stomatitis virusTrial Watch-Oncolytic viruses and cancer therapyHigh scFv-receptor affinity does not enhance the antitumor activity of HER2-retargeted measles virus.Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites.Trial watch: Oncolytic viruses for cancer therapyCharacteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligands.Ablation of nectin4 binding compromises CD46 usage by a hybrid vesicular stomatitis virus/measles virus.Oncolytic virotherapyIntratumoral immunotherapy for melanoma.Oncolytic virotherapy for urological cancers.Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity.Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spreadDARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.VSV based virotherapy in ovarian cancer: the past, the present and …future?Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activityPanorama from the oncolytic virotherapy summit.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".
P2860
Q26775038-A17C5B2E-77E8-44DD-BAA9-C022CACB4E45Q27021839-B6A8D0FF-16F1-4178-974B-910A07EFE50CQ27021951-1D3EF9E6-125B-4509-89EB-619C15880D50Q27687067-CD633173-74A4-424A-B7C2-00BA0C9E752AQ28072347-0E20F240-8E79-4012-A19A-EDF311A7493DQ33896979-236F5595-F96E-4AAE-84D2-5A57F0CE93A9Q35641491-33E0D7A1-EA4A-465F-ADE9-035DBBDBBE91Q36667968-C123958D-DBDA-40E8-A998-F925A43F70E4Q37028023-87FBD437-6BED-43DD-B040-4C1C5471EC19Q37336836-0D982318-FC93-4A9F-A7BA-13359CA9DFCFQ37547082-3D7874F7-D259-4E4D-B4DA-BAADAE3B5A29Q38025263-BB314E7F-7422-4412-A1D6-41D5D82707A6Q38518518-ACC9E732-E845-4F73-BAB7-643EDA5482F1Q38842126-FBBE1D26-1AA1-42F4-AE9C-904BA815908CQ38845078-01B52112-E851-4CA2-9C2E-60F1590682CAQ39127778-40881DB9-155F-4C26-B2FD-6DD993CB5460Q39199726-77B2837B-6793-4F2B-B21B-F286E7D888A6Q40064004-D5E44579-00BD-41D1-854F-2A85BD3F9AC4Q41441101-964C1171-B0E7-407D-8BB4-D33760BF916FQ41770092-D25576E6-8B1D-46A9-A65F-8C0C930012B9Q42934744-DC54102A-10B4-4365-8547-A9BDA64B7B2BQ45324769-F19FB559-5E2F-4D61-AACF-6CA5D4B130F2Q54378300-EAC3A84C-262F-4707-B97F-C00F2107015E
P2860
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
@ast
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
@en
type
label
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
@ast
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
@en
prefLabel
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
@ast
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
@en
P2860
P356
P1433
P1476
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
@en
P2093
Camilo Ayala-Breton
Glen N Barber
P2860
P304
P356
10.1089/HUM.2011.146
P577
2012-02-07T00:00:00Z